Related Experiment Videos
Exhaled nitric oxide in chronic obstructive pulmonary disease
W Maziak1, S Loukides, S Culpitt
1Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.
American Journal of Respiratory and Critical Care Medicine
|March 28, 1998
Summary
Exhaled nitric oxide (NO) levels are higher in patients with chronic obstructive pulmonary disease (COPD), especially during exacerbations. Higher NO correlates with poorer lung function, suggesting it can monitor COPD activity.
Area of Science:
- Respiratory Medicine
- Pulmonology
- Biomarkers
Background:
- Chronic obstructive pulmonary disease (COPD) involves progressive airflow limitation and neutrophilic inflammation.
- Exhaled nitric oxide (NO) is a potential marker for lung disease activity.
Purpose of the Study:
- To measure exhaled NO in COPD patients.
- To assess the relationship between exhaled NO and COPD severity (lung function).
- To compare exhaled NO levels in COPD patients receiving inhaled steroids versus those who are steroid-naive.
Main Methods:
- Exhaled NO was measured in current smokers with COPD, ex-smokers with COPD, patients with unstable COPD, and smokers with chronic bronchitis.
- Lung function was assessed using % predicted FEV1.
- Patients were categorized based on smoking status, disease stability, and inhaled steroid use.
Main Results:
- Exhaled NO levels were significantly higher in unstable COPD patients compared to other groups.
- Smokers with COPD had higher exhaled NO than smokers with chronic bronchitis.
- Exhaled NO showed a significant negative correlation with % predicted FEV1 (lung function).
- Patients on inhaled steroids had higher exhaled NO than steroid-naive patients, though this group had more severe disease.
Conclusions:
- Exhaled nitric oxide (NO) can serve as a practical marker for monitoring disease activity in COPD.
- NO levels may indicate disease severity and response to treatment.